India Trials For Russia’s Sputnik-V Vaccine Could Start In next Few Weeks indianexpress.com

The trials are part of a deal between the Russian Direct Investment Fund (RDIF) and Dr Reddy’s, in which the Indian firm will conduct Phase III studies in India, pursue local regulatory approvals and, subject to approval, distribute the finished vaccine product in India.